Skip to main content
. 2022 May 12;188(1):108–116. doi: 10.1093/toxsci/kfac051

Figure 2.

Figure 2.

Inhibition of basolateral bile acid transporters by CGRP compounds: (A) inhibition of MRP4 by telcagepant; (B) inhibition of MRP3 by atogepant; (C) inhibition of MRP3 by ubrogepant. Rimegepant and zavegepant did not inhibit basolateral bile acid transporters; telcagepant did not inhibit MRP3; and ubrogepant and atogepant did not inhibit MRP4.